Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03206697
Other study ID # 1606-VLC-047-MD
Secondary ID
Status Recruiting
Phase N/A
First received June 29, 2017
Last updated July 7, 2017
Start date June 30, 2017
Est. completion date February 2019

Study information

Verified date June 2017
Source Instituto Valenciano de Infertilidad, IVI VALENCIA
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The present study has the objective to study whether the mitochondrial DNA copy number values that can be generated when human embryos are analyzed for chromosomal content before embryo transfer correlates with the actual number of mitochondria as well as their energy requirements of the human embryo.


Description:

The possibility of analyzing trophectoderm cells from human blastocyst during preimplantational genetic testing offers the opportunity of analyzing not only the chromosomal constitution of the trophoblastic cells, and by extension, to infer not with certain degree of uncertainty, the chromosomal content in the inner cell cells mass and the entire embryo; but analyzing other interesting aspects related to cellular physiology such us the mtDNA content.

The number of mitochondrial copy number has a huge variation among oocytes from the same cohort and also from oocytes from different patients. It is believed that this initial number of mtDNA content is correlated with the ability of oocytes to fertilized and to achieve blastocyst stage. Whatever the initial concentration of mtDNA a given oocyte will have, it expected to equally segregate into the number of blastomeres along embryo development, so the mtDNA copy number of per daughter cell will transiently decrease, being the smallest at the blastocyst stage. Studies in different mammalian species including humans have shown that mtDNA replication does not occur before morula stage so the mitochondrial content of the oocytes should be enough to sustain embryo development before implantation occurs.

The net amount of mitochondrial DNA will exponentially increase at blastocyst stage coinciding with an increases in oxygen consumption. Despite the mtDNA copy number is higher in ICM compared to TE cells the proportion of moderate and high activity mitochondria is higher in the TE cells. This also agrees with mitochondrial morphological changes in the trophectoderm cells where mitochondria are much more elongated, less matrix electrodense and have more cristae, in ICM the will be rounded and more electrodense.

The objective of the present work is to analyze whether a correlation exist between the mitochondrial DNA copy number and both the actual number of mitochondria in the blastocyst and the metabolic needs of the human blastocysts and the ATP production.


Recruitment information / eligibility

Status Recruiting
Enrollment 171
Est. completion date February 2019
Est. primary completion date December 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 5 Days
Eligibility Inclusion Criteria of women whose blastocysts will undergo PGT-A and be eligible for study:

- > 38 years old

- Sperm count: > 2 million spermatozoids/ml

- Oocytes retrieved > 4 oocytes MII

- Antral Follicles (AFC: =4)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Mitochondrial DNA content and metabolic parameters
Analyze the correlation between the mitochondrial DNA content and metabolic parameters.

Locations

Country Name City State
Spain Maria Jose DeLosSantos Valencia

Sponsors (2)

Lead Sponsor Collaborator
Instituto Valenciano de Infertilidad, IVI VALENCIA Igenomix

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Correlation between mitochondrial DNA content and number of mitochondria and Correlation between mitochondrial DNA content and metabolic turnover Correlation index between each variable Each embryo will need an average of one week for assessment